NCT02066207
CKD-337 Drug Interaction Study treatment 1 completed NCT00396240
ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals treatment 4 withdrawn NCT00269204
Lipid Efficacy/Tolerability Study (0524A-020) treatment 3 completed NCT02009787
Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia treatment Not Available unknown_status NCT00871351
Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED) treatment 4 completed NCT05131997
A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A treatment 3 completed NCT01294683
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) treatment 3 terminated NCT05930028
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia treatment 3 recruiting NCT00479388
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) treatment 3 completed NCT05559606
An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe No drug interventions Not Available Not Available recruiting NCT02205606
Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia No drug interventions treatment 3 completed NCT04652349
Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia No drug interventions treatment 3 completed NCT04584736
To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia treatment 3 completed NCT01879319
Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen treatment 3 completed NCT06314919
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib No drug interventions Not Available Not Available recruiting NCT06386419
A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia treatment 4 not_yet_recruiting NCT02087917
A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia No drug interventions treatment 2 completed NCT00269217
Lipid Efficacy Study (0524B-022)(COMPLETED) treatment 3 completed NCT00704535
Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED) Not Available Not Available completed NCT05118230
Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia No drug interventions Not Available Not Available completed NCT02941848
Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers No drug interventions treatment 1 completed NCT05657574
A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia No drug interventions treatment 3 recruiting NCT00479882
MK-0524B Lipid Study (MK-0524B-063) treatment 3 completed NCT03413462
Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia No drug interventions treatment 3 completed NCT05399992
Study Evaluating Effectiveness and Adherence of Inclisiran Plus Standard of Care (SoC) Lipid-lowering Therapy Compared to SoC in ASCVD No drug interventions Not Available Not Available recruiting NCT06165250
A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C No drug interventions treatment 3 recruiting NCT00941603
Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) treatment 2 completed NCT03571087
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia treatment 3 completed NCT00724477
Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED) No drug interventions Not Available Not Available completed NCT03882905
A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173) treatment 3 completed NCT01335997
Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143) treatment 3 terminated NCT01849497
Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen treatment 3 completed NCT00746811
Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia treatment 4 completed NCT04643093
Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia treatment 3 completed NCT06568471
A Study on Efficacy and Safety of HST101 in Chinese Patients With Hypercholesterolemia treatment 3 not_yet_recruiting NCT05206578
Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia No drug interventions treatment 3 unknown_status NCT02445352
Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia treatment 3 completed NCT04849000
Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage treatment 3 completed NCT01274559
Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133) treatment 3 terminated NCT04659070
To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia treatment 3 unknown_status NCT00249249
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels treatment 3 completed NCT01012219
A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) treatment 1 completed NCT04844125
SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research treatment 3 completed NCT00867165
Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522) treatment 3 completed NCT03464682
Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia treatment 3 unknown_status NCT06448962
Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022 No drug interventions treatment 3 completed NCT06475872
Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects treatment 1 completed NCT06184269
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B" No drug interventions treatment 1 completed NCT03952169
Effect of Probiotics on Lipid Management No drug interventions prevention Not Available unknown_status NCT03433755
Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia treatment 3 terminated NCT03516955
Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting Not Available Not Available completed NCT05798390
Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia Not Available Not Available withdrawn NCT00776321
Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia prevention 2 completed NCT05638022
Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic No drug interventions Not Available Not Available unknown_status NCT01577056
Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils No drug interventions treatment Not Available unknown_status NCT01078675
An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia treatment 3 completed NCT06275724
Specified Drug-use Survey of Leqvio for s.c. Injection. No drug interventions Not Available Not Available recruiting NCT02693548
The Spanish Familial Hypercholesterolaemia Cohort Study No drug interventions Not Available Not Available recruiting NCT05181553
Unravelling the Impact of Diet on Cardiovascular Health in Heterozygous Familial Hypercholesterolemia. No drug interventions prevention Not Available recruiting NCT02489253
Atherosclerosis in Familial Hypercholesterolemia No drug interventions Not Available Not Available unknown_status NCT05746247
Improving Diagnosis and Clinical Management of Familial Hypercholesterolemia Through Integrated Machine Learning, Implementation Science, and Behavioral Economics No drug interventions diagnostic Not Available enrolling_by_invitation NCT05425745
Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. treatment 3 completed NCT05271305
Pilot Study for a National Screening for Familial Hypercholesterolemia No drug interventions Not Available Not Available unknown_status NCT05218005
Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia No drug interventions diagnostic Not Available recruiting NCT04272697
EAS Familial Hypercholesterolaemia Studies Collaboration No drug interventions Not Available Not Available recruiting NCT04656028
Genetic Testing and Motivational Counseling for FH No drug interventions treatment Not Available recruiting NCT01138371
Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers No drug interventions Not Available Not Available completed NCT03152656
A Registration Study for Familial Hypercholesterolemia in Taiwan No drug interventions Not Available Not Available unknown_status NCT03832985
Pediatric Reporting of Adult-Onset Genomic Results No drug interventions health_services_research 0 active_not_recruiting NCT05695937
Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Patients With Familial Hypercholesterolemia No drug interventions treatment Not Available active_not_recruiting NCT06546137
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry No drug interventions Not Available Not Available not_yet_recruiting NCT03253432
IN-TANDEM Familial Hypercholesterolemia Pilot Study No drug interventions Not Available Not Available completed NCT05066932
Advanced Lipoproptein Profiling and Cardiovascular Risk Stratification in Familial Hypercholesterolemia No drug interventions Not Available Not Available unknown_status NCT00827606
Atorvastatin Three Year Pediatric Study treatment 3 completed NCT04101149
Genetic Causes of Familial Hypercholesterolemia No drug interventions Not Available Not Available recruiting NCT05284513
Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH) No drug interventions other Not Available enrolling_by_invitation NCT02013713
French Observatory of Familial Hypercholesterolemia in Cardiology No drug interventions Not Available Not Available terminated NCT05614219
Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection. No drug interventions screening Not Available not_yet_recruiting NCT00924339
Soy Food Intervention Trial No drug interventions treatment Not Available unknown_status NCT05142722
Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies treatment 3 active_not_recruiting NCT06389825
Unravelling the Impact of Diet on Cardiovascular Health in Treated Heterozygous Familial Hypercholesterolemia. No drug interventions treatment Not Available recruiting NCT06571630
PMMHRI - Familial Hypercholesterolemia Registry No drug interventions Not Available Not Available recruiting NCT02729857
Postprandial Response After Intake of Meals With Different Fatty Acid Composition No drug interventions prevention Not Available completed NCT04929457
Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia No drug interventions Not Available Not Available enrolling_by_invitation NCT03331666
Impact of LDL-cholesterol Lowering on Platelet Activation prevention 4 terminated NCT04458766
The Use of Mobile Health Technology and Behavioral Economics to Encourage Adherence in Adolescents No drug interventions treatment Not Available completed NCT00655265
A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing Medication treatment 4 completed NCT00924274
Effect of Rapeseed Oil and Sunflower Oil No drug interventions treatment Not Available unknown_status NCT03934320
Improving Identification of Familial Hypercholesterolaemia in Primary Care (FAMCAT) No drug interventions diagnostic Not Available unknown_status NCT06362473
Lipid Transport Disorder Italian Genetic Record (LIPIGEN) No drug interventions Not Available Not Available recruiting NCT02750527
Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany No drug interventions Not Available Not Available completed NCT02870660
Familial Hypercholesterolemia Amongst Patients With Acute Coronary Syndrome No drug interventions Not Available Not Available unknown_status NCT02865694
Developing and Implementing Familial Hypercholesterolemia Registry No drug interventions Not Available Not Available unknown_status NCT06293729
Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients No drug interventions treatment 0 not_yet_recruiting NCT00704444
A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244) Not Available Not Available completed NCT04529967
Child-Parent Familial Hypercholesterolemia Screening No drug interventions Not Available Not Available not_yet_recruiting NCT02208869
Russian Familial Hypercholesterolemia Registry No drug interventions Not Available Not Available recruiting NCT02624869
Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia) treatment 3 completed NCT00079846
Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy treatment 2 terminated NCT02048410
Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia No drug interventions treatment 1 / 2 completed NCT06458010
Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH) No drug interventions treatment 0 recruiting NCT04455581
A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia treatment 2 unknown_status NCT06331195
An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH) No drug interventions treatment Not Available not_yet_recruiting NCT03110250
Familial Hypercholesterolemia in Turkey (A-HIT2) No drug interventions Not Available Not Available completed NCT02709850
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia No drug interventions other 1 completed NCT00751608
Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients No drug interventions basic_science 2 withdrawn NCT01107743
Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) Not Available Not Available completed NCT02808403
Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan No drug interventions Not Available Not Available completed NCT04507984
Universal Familial Hypercholesterolemia Screening in Children No drug interventions Not Available Not Available completed NCT05758779
The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial No drug interventions prevention Not Available recruiting NCT03756779
Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia No drug interventions treatment Not Available withdrawn NCT06439654
Atlantic Lipid Lowering Treatment Optimization Program No drug interventions supportive_care Not Available not_yet_recruiting NCT03398954
a Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial Hypercholesterolemia No drug interventions Not Available Not Available unknown_status NCT03060577
An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol treatment 2 completed NCT02009345
Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada No drug interventions Not Available Not Available recruiting NCT03140605
Greek Registry - Familial Hypercholesterolaemia No drug interventions Not Available Not Available unknown_status NCT01783405
Cardiovascular Disease in FH Heterozygous No drug interventions Not Available Not Available unknown_status NCT06005597
Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies treatment 3 active_not_recruiting NCT00705211
A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245) Not Available Not Available completed NCT03310671
Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With Statins No drug interventions Not Available Not Available unknown_status NCT05465278
Alirocumab and Plaque Burden In Familial Hypercholesterolaemia treatment 4 completed NCT00004809
Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia No drug interventions treatment 1 completed NCT05952856
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids No drug interventions treatment 3 active_not_recruiting NCT00355615
PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin treatment 3 completed NCT03884452
Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018) treatment 3 completed NCT00079859
Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy treatment 2 terminated NCT04941599
2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH) prevention 2 recruiting NCT04370899
Early Detection of Familial Hypercholesterolemia in Children No drug interventions Not Available Not Available recruiting NCT01813006
Effect of Omega-3 Fatty Acid on Endothelial Function treatment 3 completed NCT00943306
Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia treatment 3 completed NCT05238519
Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH) No drug interventions screening 3 recruiting NCT03640234
Return of Actionable Variants Empirical Study No drug interventions Not Available Not Available completed NCT03747224
Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients treatment 1 completed NCT03597958
Genetic Causes of Hypercholesterolaemia in the Emirati Population No drug interventions Not Available Not Available unknown_status NCT05352386
Coronary and Heart Effects of Early Treatment in Familial Hypercholesterolemia No drug interventions diagnostic Not Available completed NCT04798430
Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction treatment 3 enrolling_by_invitation NCT02748057
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833) treatment 3 completed NCT05261126
A Study of the Efficacy and Safety of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008) No drug interventions treatment 2 completed NCT05851066
A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers No drug interventions treatment 1 not_yet_recruiting NCT02597127
Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) treatment 2 completed NCT05430191
Equitable Implementation of Cascade Screening for Familial Hypercholesterolemia No drug interventions Not Available Not Available completed NCT04958629
A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population No drug interventions Not Available Not Available unknown_status NCT02225340
Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia No drug interventions Not Available Not Available completed NCT05750667
Penn Family Screening for Familial Hypercholesterolemia No drug interventions health_services_research Not Available enrolling_by_invitation NCT03900169
Familial Hypercolerstremia as Risk Factor in Stemi Patient Who Underwent Ppci No drug interventions Not Available Not Available unknown_status NCT05952869
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017) CORALreef HeFH No drug interventions treatment 3 active_not_recruiting NCT02778646
Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry No drug interventions Not Available Not Available completed NCT05825612
EPIRUS FH Reverse Cascade Screening No drug interventions Not Available Not Available not_yet_recruiting NCT05367310
Effect of Breastfeeding on Lipid Profile and Cardiovascular Risk Markers in Women With Familial Hypercholesterolemia No drug interventions Not Available Not Available recruiting NCT05043181
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH No drug interventions treatment 1 not_yet_recruiting NCT02462655
Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia No drug interventions treatment Not Available completed NCT00916643
Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy No drug interventions treatment 4 completed NCT04419090
Cascade Genetic Testing of Familial Hypercholesterolemia No drug interventions screening Not Available completed NCT04494464
Treatment Rates and Compliance to Treatment in Patients With Familial Hypercholesterolemia No drug interventions Not Available Not Available completed NCT05348564
Comparing Direct vs Indirect Methods for Cascade Screening No drug interventions screening Not Available recruiting NCT06461702
Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH) No drug interventions treatment 0 recruiting NCT00092833
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED) treatment 3 terminated NCT01375751
Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study treatment 2 completed NCT00384293
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) treatment 3 terminated NCT00515307
Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia No drug interventions treatment 1 completed NCT00134485
Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia treatment 3 completed NCT04526457
Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia No drug interventions other Not Available completed NCT00000594
NHLBI Type II Coronary Intervention Study prevention 3 completed NCT01524289
Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) treatment 3 completed NCT03989167
Clinical Decision Support for Familial Hypercholesterolemia No drug interventions diagnostic Not Available recruiting NCT00005168
Hyperapo B and Coronary Heart Disease No drug interventions Not Available Not Available completed NCT04722068
Regeneron 1331 Kinetics Sub-Study HoFH No drug interventions other Not Available completed NCT00136981
Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. treatment 3 completed NCT00281008
Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy No drug interventions treatment 2 completed NCT04837638
Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia No drug interventions Not Available Not Available active_not_recruiting NCT01583647
A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) treatment 1 terminated NCT04073797
PET Imaging of Inflammation and Lipid Lowering Study diagnostic Not Available recruiting NCT00134511
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder treatment 3 completed NCT03018678
Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia No drug interventions Not Available Not Available completed NCT01753232
Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter No drug interventions Not Available Not Available completed NCT06231459
Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia treatment 4 completed NCT04313270
Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab® Not Available Not Available recruiting NCT04118348
Evaluating the Efficacy of Pediatric Lipid Screening Alerts No drug interventions screening Not Available completed NCT06555120
Screening for Familial Hypercholesterolemia in Children No drug interventions screening Not Available not_yet_recruiting NCT00280995
Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy treatment 2 completed NCT03795038
Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI No drug interventions treatment Not Available completed